These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32653653)

  • 1. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
    Leurs A; Dubucquoi S; Machuron F; Balden M; Renaud F; Rogeau S; Lopez B; Lambert M; Morell-Dubois S; Maillard H; Béhal H; Hachulla E; Launay D; Sobanski V
    Joint Bone Spine; 2021 Jan; 88(1):105048. PubMed ID: 32653653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
    Montagnese F; Babačić H; Eichhorn P; Schoser B
    J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anti-synthetase antibodies among systemic sclerosis patients.
    Garra W; Levy Y
    Eur J Intern Med; 2023 Nov; 117():98-102. PubMed ID: 37453844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
    Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
    Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
    Platteel ACM; Wevers BA; Lim J; Bakker JA; Bontkes HJ; Curvers J; Damoiseaux J; Heron M; de Kort G; Limper M; van Lochem EG; Mulder AHL; Saris CGJ; van der Valk H; van der Kooi AJ; van Leeuwen EMM; Veltkamp M; Schreurs MWJ; Meek B; Hamann D
    J Transl Autoimmun; 2019 Dec; 2():100013. PubMed ID: 32743501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies.
    Conticini E; d'Alessandro M; Cameli P; Bergantini L; Pordon E; Cassai L; Cantarini L; Bargagli E; Frediani B; Porcelli B
    Immunol Res; 2023 Oct; 71(5):735-742. PubMed ID: 37133680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two clusters of systemic lupus erythematosus patients with muscle involvement in a Chinese cohort.
    Zhao L; Huang W; Wang H; Chen J; Zhang D; Wang X; Sun F; Ye S
    Int J Rheum Dis; 2023 Jan; 26(1):51-59. PubMed ID: 36117395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
    Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
    Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study.
    Lackner A; Tiefenthaler V; Mirzayeva J; Posch F; Rossmann C; Kastrati K; Radner H; Demel U; Gretler J; Stotz M; Graninger WB; Stradner MH
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X20975907. PubMed ID: 33343724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis - a cohort study of 70 adult patients with myositis in a single center.
    Marklund J; Hanna B; Jin T; Pullerits R
    Front Med (Lausanne); 2024; 11():1340310. PubMed ID: 38606156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
    Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients.
    Negalur NV; Ekbote GG; Raval DN; Tanna DV; Kazi WS; Bindroo MA; Yadavalli DJ; Gupta R
    Ann Indian Acad Neurol; 2021; 24(4):552-558. PubMed ID: 34728950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot.
    Bories E; Fortenfant F; Pugnet G; Renaudineau Y; Bost C
    Semin Arthritis Rheum; 2022 Aug; 55():151998. PubMed ID: 35427882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
    Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
    Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation study on anti-Ro52 antibodies frequently co-occur with other myositis-specific and myositis-associated autoantibodies].
    Zheng YM; Hao HJ; Liu YL; Guo J; Zhao YW; Zhang W; Yuan Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1088-1092. PubMed ID: 33331318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies.
    Maundrell A; Proudman S; Limaye V
    Rheumatol Int; 2019 Oct; 39(10):1777-1781. PubMed ID: 31385080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.